Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?

Cancer

Volumn 116, Issue 10, 2010, Pages 2416-2428

  Kanetsky, Peter A ^a,b   Panossian, Saarene ^a   Elder, David E ^a,b   Guerry, DuPont ^a,b   Ming, Michael E ^a,b   Schuchter, Lynn ^a,b   Rebbeck, Timothy R ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Genetic variation; Melanocortin 1 receptor; Melanoma; Pigmentation phenotype

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; EYE COLOR; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAIR COLOR; HUMAN; LENTIGO; MAJOR CLINICAL STUDY; MC1R GENE; MELANOMA; OCCUPATIONAL EXPOSURE; ONCOGENE; PRIORITY JOURNAL; SELF REPORT; SKIN EXAMINATION; SKIN PIGMENTATION; SUN EXPOSURE; CASE CONTROL STUDY; FEMALE; GENETICS; MALE; META ANALYSIS; MIDDLE AGED; PATHOLOGY; PHENOTYPE; RISK; SKIN TUMOR; SUNLIGHT;

MELANOCORTIN 1 RECEPTOR;

CASE-CONTROL STUDIES; FEMALE; GENETIC VARIATION; GENOTYPE; HAIR COLOR; HUMANS; MALE; MELANOMA; MIDDLE AGED; PHENOTYPE; RECEPTOR, MELANOCORTIN, TYPE 1; RISK; SKIN NEOPLASMS; SKIN PIGMENTATION; SUNLIGHT;

EID: 77952564907     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24994     Document Type: Article

References (23)

1. Bliss JM, Ford D, Swerdlow AJ, et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. Int J Cancer. 1995;62:367-376.
2. Chang YM, Newton-Bishop JA, Bishop DT, et al. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int J Cancer. 2009; 124:420-428.
3. Gerstenblith MR, Goldstein AM, Fargnoli MC, Peris K, Landi MT. Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat. 2007;28:495-505. (Pubitemid 46668608)
4. Landi MT, Kanetsky PA, Tsang S, et al. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst. 2005;97:998-1007; erratum 2005;97:1385; comment 2006;98:144-145; author reply 2006;98:145-146.
5. Palmer JS, Duffy DL, Box NF, et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet. 2000;66:176-186.
6. Dwyer T, Stankovich JM, Blizzard L, et al. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? Am J Epidemiol. 2004; 159:826-833.
7. Raimondi S, Sera F, Gandini S, et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer. 2008;122:2753-2760. (Pubitemid 351631377)
8. Gimotty PA, Elder DE, Fraker DL, et al. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol. 2007;25:1129-1134.
9. Kanetsky PA, Holmes R, Walker A, et al. Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma. Cancer Epidemiol Biomarkers Prev. 2001;10:509-513. (Pubitemid 32701638)
10. Kanetsky PA, Ge F, Najarian D, et al. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiol Biomarkers Prev. 2004;13:808-819.
11. Kanetsky PA, Rebbeck TR, Hummer AJ, et al. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res. 2006;66:9330-9337.
12. Sturm RA, Duffy DL, Box NF, et al. The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes. Pigment Cell Res. 2003;16:266-272.
13. Fargnoli MC, Altobelli E, Keller G, Chimenti S, Hofler H, Peris K. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study. Melanoma Res. 2006; 16:175-182. (Pubitemid 44090049)
14. Stratigos AJ, Dimisianos G, Nikolaou V, et al. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. J Invest Dermatol. 2006;126:1842-1849; comment 2006; 126:1691-1692.
15. Ichii-Jones F, Lear JT, Heagerty AH, et al. Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol. 1998;111:218-221; comment 1999;112:512-513.
16. Kennedy C, ter Huurne J, Berkhout M, et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol. 2001;117:294-300. (Pubitemid 34205714)
17. Gudbjartsson DF, Sulem P, Stacey SN, et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet. 2008;40:886-891.
18. Beaumont KA, Shekar SN, Cook AL, Duffy DL, Sturm RA. Red hair is the null phenotype of MC1R. Hum Mutat. 2008;29:E88-E94.
19. Berwick M, Orlow I, Hummer AJ, et al. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol Biomarkers Prev. 2006;15:1520-1525.
20. Fears TR, Guerry DT, Pfeiffer RM, et al. Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol. 2006;24:3590-3596.
21. Cho E, Rosner BA, Feskanich D, Colditz GA. Risk factors and individual probabilities of melanoma for whites. J Clin Oncol. 2005;23:2669-2675. (Pubitemid 46179456)
22. Whiteman DC, Green AC. A risk prediction tool for melanoma? Cancer Epidemiol Biomarkers Prev. 2005;14:761-763.
23. Janes H, Pepe MS, Gu W. Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med. 2008;149:751-760.